A bioelectrochemical system (BES) that enhances biological nitrogen removal in urban bioretention cells by enriching electroactive denitrification and anammox bacteria. Powered by on-site solar panels, the technology targets nitrate, ammonium, and nitrite in stormwater without adding external carbon sources or introducing new pollutants.
Urban stormwater bioretention systems often underperform in nitrogen removal because traditional heterotrophic denitrification requires supplemental carbon sources and can export residual pollutants. This research proposes a bioelectrochemical approach that enriches electroactive nitrogen-processing microorganisms directly within bioretention cells. By applying low-energy electrical input from on-site solar panels, the system promotes autotrophic denitrification on cathodes and supports anammox bacteria capable of converting ammonium and nitrite into nitrogen gas under anaerobic conditions. The result is improved nitrogen removal performance in both existing and newly constructed bioretention infrastructure without the need for external chemical inputs.
The technology is at an early-to-mid research and development stage. Bioelectrochemical systems have previously demonstrated promising nitrogen removal results in wetlands and low-concentration wastewater treatment. Future validation will proceed in two phases: first, rapid enrichment of electroactive nitrogen-processing bacteria using mesocosm columns with carbon electrodes and solar-powered cycling, with biofilm community analysis every 10 to 20 cycles; second, system performance assessment using simulated stormwater at varying nitrogen concentrations, flow rates, and durations to determine nitrogen removal rates and establish scale-up parameters.
The University of Maryland is the state's flagship public research university in College Park, serving a large student body and offering comprehensive academic and research programs. Industry engages through an adjacent research park, shared prototyping facilities, and dedicated corporate partnership channels, plus joint pathways to a medical campus for clinical and regulatory engagement. Its Washington–Baltimore location places partners near federal agencies, national labs, and prime contractors, while a statewide extension network supports collaboration with companies. Research is backed by competitive federal funding from agencies such as NSF, NIH, DoD, DOE, NASA, and USDA, and coordinated commercialization services advance IP, startup formation, licensing, and industry-sponsored research.